RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31727365http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31727365http://www.w3.org/2000/01/rdf-schema#comment"Dysregulation of apoptotic and autophagic function are characterized as the main pathogeneses of diabetic nephropathy (DN). It has been reported that Karyopherin Alpha 2 (KPNA2) contributes to apoptosis and autophagy in various cells, but its role in DN development remains unknown. The purpose of present study was to explore the function and underling mechanisms of KPNA2 in development of DN. In this study, 30 mM high glucose (HG)-evoked podocytes were used as DN model. The expression of KPNA2 was detected by qRT-PCR and Western blot assays. The cell viability was tested by CCK-8 kit, the apoptosis was measured using flow cytometry assay, the apoptotic and the autophagy related genes was detected by Western blot. Our results indicated that KPNA2 was significantly increased after HG stimulation. Knockdown of KPNA2 inhibited apoptosis, and promoted cell viability and autophagy in HG-treated podocytes. In addition, silencing of KPNA2 deactivated mTORC1/p70S6K pathway activation via regulating SLC1A5. Further results demonstrated that activating mTORC1/p70S6K pathway strongly ameliorated the effect of KPNA2 on cell viability, apoptosis and autophagy. Therefore, our study suggested that knockdown of KPNA2 rescued HG-induced injury via blocking activation of mTORC1/p70S6K pathway by mediating SLC1A5."xsd:string
http://purl.uniprot.org/citations/31727365http://purl.org/dc/terms/identifier"doi:10.1016/j.bbrc.2019.10.200"xsd:string
http://purl.uniprot.org/citations/31727365http://purl.uniprot.org/core/author"Fan X."xsd:string
http://purl.uniprot.org/citations/31727365http://purl.uniprot.org/core/author"Hao Z."xsd:string
http://purl.uniprot.org/citations/31727365http://purl.uniprot.org/core/author"Li Z."xsd:string
http://purl.uniprot.org/citations/31727365http://purl.uniprot.org/core/author"Wang J."xsd:string
http://purl.uniprot.org/citations/31727365http://purl.uniprot.org/core/author"Wang X."xsd:string
http://purl.uniprot.org/citations/31727365http://purl.uniprot.org/core/date"2020"xsd:gYear
http://purl.uniprot.org/citations/31727365http://purl.uniprot.org/core/name"Biochem Biophys Res Commun"xsd:string
http://purl.uniprot.org/citations/31727365http://purl.uniprot.org/core/pages"1017-1023"xsd:string
http://purl.uniprot.org/citations/31727365http://purl.uniprot.org/core/title"Silencing of KPNA2 inhibits high glucose-induced podocyte injury via inactivation of mTORC1/p70S6K signaling pathway."xsd:string
http://purl.uniprot.org/citations/31727365http://purl.uniprot.org/core/volume"521"xsd:string
http://purl.uniprot.org/citations/31727365http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31727365
http://purl.uniprot.org/citations/31727365http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/31727365
http://purl.uniprot.org/uniprot/#_A8K7D9-mappedCitation-31727365http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31727365
http://purl.uniprot.org/uniprot/#_P52292-mappedCitation-31727365http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31727365
http://purl.uniprot.org/uniprot/#_Q7Z726-mappedCitation-31727365http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31727365
http://purl.uniprot.org/uniprot/Q7Z726http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/31727365
http://purl.uniprot.org/uniprot/P52292http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/31727365
http://purl.uniprot.org/uniprot/A8K7D9http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/31727365